PhD (Queensland University of Technology), Bachelor of Applied Science (Honours) (Life Science) (Queensland University of Technology), Bachelor of Applied Science (Biotechnology) (Queensland University of Technology)
Mark Adams is currently a Senior Research Fellow (Competitive Grant Researcher Agreement) at Queensland University of Technology (QUT). He completed his PhD at the Mater Research Institute-University of Queensland in 2012 and with the support of an NHMRC Early Career Fellowship, he commenced postdoctoral work at the Translational Research Institute (TRI) on the Princess Alexandra Hospital campus with QUT. Dr Adams is now based at Kelvin Grove, QUT where his team’s research focus is seeking to exploit cellular programs that regulate genome instability, cell cycle and cell growth to identify novel therapeutic avenues and improve therapy response for lung cancers.
Dr Adams’ work is published in leading journals including Journal of Thoracic Oncology, Nature Communications and Nucleic Acids Research and has received funding support from the Queensland Government, NHMRC, the International Lung Cancer Foundation and Cancer Australia. His research excellence has enabled filing of patents (one at national phase) and been recognised with >10 conference or institutional awards including Runner-up Cure Cancer Researcher of the Year (2023, Admiralty House Sydney), OneTRI Awards (promoting inclusion & culture), 2022 Young Tall Poppy and 1st place Australian Society of Medical Research Qld postdoctoral award.